Barrington Research Maintains Outperform Rating for US Physical Therapy: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Barrington Research has reaffirmed its Outperform rating on US Physical Therapy (NYSE:USPH) and increased its price target from $111.00 to $120.00. The current share price is $93.47, and the new price target suggests a potential upside of 28.38%. US Physical Therapy operates outpatient physical therapy clinics and generates most of its revenue from the Physical therapy operations segment.
January 03, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research maintains Outperform rating on US Physical Therapy and raises price target to $120, indicating a significant potential upside from the current price.
The reaffirmation of the Outperform rating and the increase in price target by Barrington Research are strong positive signals for investors, suggesting confidence in the company's future performance. This could lead to increased investor interest and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100